1.06
+0.03(+2.91%)
Currency In USD
Address
5251 Edina Industrial Boulevard
Minneapolis, MN 55439
United States of America
Phone
952 405 6216
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
20
First IPO Date
September 08, 2014
| Name | Title | Pay | Year Born |
| Mr. John Lai | Chief Executive Officer, President & Director | 353,912 | 1962 |
| Mr. Garry N. Lowenthal | Chief Financial Officer | 32,778 | 1959 |
| Mr. John F. Dolan | General Counsel, Chief Business Development Officer & Secretary | 40,250 | 1965 |
| Ms. April Boyce | Vice President of Sales & Marketing | 0 | N/A |
| Mr. Michael Eldred BA, MBA | Commercialization & Operations Advisor and Executive Director | 0 | 1970 |
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.